StonvexLoading…
StonvexStonvexStonvexCore line items from ATNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $90.00K | $90.00K | $81.00K | $1.03M |
Operating Income | $-36.25M | $-29.83M | $-51.92M | $-34.10M |
Net Income | $-33.89M | $-27.95M | $-48.82M | $-33.02M |
EPS (Diluted) | $-1.09 | $-0.90 | $-1.83 | $-1.37 |
Total Assets | $51.77M | $56.15M | $81.44M | $114.19M |
Total Liabilities | $43.94M | $42.37M | $45.07M | $47.71M |
Cash & Equivalents | $48.00M | $53.39M | $76.68M | $108.91M |
Free Cash Flow OCF − CapEx | $-24.68M | Not available | $-47.49M | $8.28M |
Shares Outstanding | 31.20M | 31.20M | 27.63M | 25.67M |